Business Context and Reporting Period
This Form 6-K filing by Coca-Cola Europacific Partners Plc (CCEP) is dated April 15, 2021. The report announces the receipt of final regulatory approval from the Overseas Investment Office (OIO) of New Zealand for CCEP's proposed acquisition of Coca-Cola Amatil Limited (CCL). CCEP is the world's largest Coke bottler by revenue, serving over 300 million consumers in Western Europe. CCL is a major bottler in the Asia Pacific region, operating in Australia, New Zealand, Fiji, Indonesia, Papua New Guinea, and Samoa.
Key Financial Metrics
The filing does not provide current financial results, revenue, profit, cash flow, or debt metrics for CCEP for the reporting period. It references historical data for CCL from Fiscal Year 2019:
- CCL FY19 Revenue: A$5.1 billion (approximately €3.1 billion).
- CCL FY19 EBITDA: A$1.0 billion (approximately €0.6 billion).
- Geographic Split: Approximately three-quarters of CCL's revenue is generated from Australia and New Zealand.
Current liquidity, margins, and debt levels for CCEP are not disclosed in this document.
Material Changes and Transaction Status
The primary material change is the progression of the acquisition of CCL. Key developments include:
- Regulatory Approvals: CCEP previously received approval from the Australian Foreign Investment Review Board (FIRB) on January 29, 2021, and confirmed receipt of the New Zealand OIO approval on April 15, 2021.
- Remaining Conditions: The transaction remains subject to CCL Independent Shareholder approval at the Scheme Meeting and court approval.
- Indicative Timetable:
- Scheme Meeting: April 16, 2021
- Effective Date: April 21, 2021
- Implementation Date: May 10, 2021
Outlook, Risks, and Management Commentary
Management emphasizes that the transaction is subject to customary conditions and that the provided timetable is indicative. The filing contains extensive forward-looking statements regarding the integration of CCL into CCEP.
Key Risks Identified:
- Integration Risks: Potential difficulties, delays, or higher costs in integrating the businesses, which could disrupt operations and divert management attention.
- Regulatory and Approval Risks: Failure to obtain necessary shareholder or court approvals, or the imposition of burdensome conditions.
- COVID-19 Impact: Uncertainty regarding the pandemic's scope and duration, which could adversely affect financial results, operations, and demand.
- Operational and Market Risks: Includes supply chain disruptions, packaging regulations, climate change legislation, foreign exchange fluctuations, and cybersecurity threats.
- Financing Risks: The ability to raise necessary financing for the acquisition.
Investor Verification Checklist
- Confirm the outcome of the CCL Independent Shareholder vote scheduled for April 16, 2021.
- Verify the receipt of final court approval for the Scheme Implementation.
- Review CCEP's financing arrangements to ensure the ability to fund the acquisition.
- Monitor updates on the integration plan and potential synergies between CCEP and CCL.
- Assess the impact of ongoing COVID-19 restrictions on beverage demand in both Western Europe and the Asia Pacific region.